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Poecilocerus pictusAbstract Purpose: To understand the role of hyperthermia in adaptive response, Ethyl methane-
sulfonate (EMS) an anticarcinogenic agent, adapted meiotic cells of Poecilocerus pictus was used.
Materials and methods: Based on the pilot toxicity study, the effective higher temperatures of
40 C and 45 C for 15 or 30 min were chosen. P. pictus were treated with conditioning (L) or
challenging (H) doses of EMS and 2 h time lag (TL) between these doses (L-2 h-H) was employed.
Different treatment schedules were used to analyze the inﬂuence of hyperthermia on EMS induced
adaptive response namely (i) pre treatment; (ii) inter treatment; (iii) post treatment and (iv) cross
adaptation. After each treatment schedule, animals were sacriﬁced at 12, 24, 36 and 48 h recovery
times, testes were processed for meiotic chromosome preparations and anomalies were analyzed.
Results: The frequencies of anomalies induced by both conditioning and challenging doses of
EMS were signiﬁcantly higher (p< 0.05) compared to those of the control and hyperthermia
groups. The combined treatments resulted in 44–50% reduction compared to additive effect of
EMS. The pre, inter, post and cross adaptation treatments with hyperthermia signiﬁcantly reduced
the frequencies of chromosomal anomalies compared to the challenge and combined treatments
with EMS at all recovery times (p< 0.05) tested.
Conclusion: There is a protection against EMS induced anomalies by hyperthermia in in vivo
P. pictus. As far as our knowledge is concerned, this is the ﬁrst report to demonstrate that
hyperthermia enhances the EMS induced adaptive response in in vivo meiotic cells.
 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of Ain Shams University. This is
an open access article under theCCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Cancer is one of the leading causes of death worldwide and
accounted for 8.2 million deaths in 2012 [1]. Depending on
the type and stage of cancer, treatments to eradicate the tumor
or slow its growth include some combination of surgery, radi-
ation therapy and chemotherapy [2]. Recent alternative tar-
geted therapies are employed namely hyperthermia, hormone
therapies, signal transduction inhibitors, gene expression
modulator, apoptosis inducer, angiogenesis inhibitor,
immunotherapies and toxin delivery molecules [3,4]. Hyper-
thermia (thermal therapy or thermotherapy) is a type of cancer
treatment in which body tissue is exposed to high temperatures
(range between 41 C and 45 C) to damage and kill cancer
cells. It is a good therapeutic tool for non-invasive cancer
therapy and is being employed along with traditional radio-
therapy, chemotherapy and combination of both (triple
modality) [5]. It has also been observed that hyperthermia
allows clinicians to reduce doses of anticancer drugs and
radiations administered to patients. The reduction of the doses
helps, consequently, the reduction of anticancer therapy side
effects [6]. Therefore, hyperthermia aims at improving the
results of the conventional treatment strategies within a
framework of multi-model treatments.
Working with anti-cancerous agents, Scientists have
noticed the protection of cells to lethal dose, when these are
pre-exposed to low doses. This has come to be known as
‘adaptive response’ [7] which refers to the ability of cells or
organisms to better resist the damaging effects of toxic agent
when ﬁrst pre exposed to a lower dose. When treatment with
anti-neoplastic drugs is pursued over a long period, depending
on the doses employed, adaptive response, if induced in the
cells and tissues involved, can modify the efﬁcacy of the
treatment leading to drug or radio-resistance [8,9]. The timing
of heat exposure, before or after the ultra violet (UV) or
N-methyl-N0-nitro-N-nitrosoguanidine (MNNG) treatments,
had no effect on the result in cases of cytotoxicity and mutage-
nesis [10]. Contrarily, the mild hyperthermia (41 C for 1 h)
can induce adaptation to cytogenetic damages caused by sub-
sequent mutagenic agents [11–14]. Studies with hyperthermia
showed that it caused radiosensitization or chemosensitization
[15,16]. It is clear from the published data; that there are
contradictory reports about the action of hyperthermia and
induction of adaptive response by hyperthermia in combina-
tion with mutagen. Even though, a few reports are available
on the adaptive response in mouse, Poecilocerus pictus,
Drosophila, plant (Vicia faba) and human test systems
[17–24] using alkylating agents, the inﬂuence of hyperthermia
has not been analyzed. Further P. pictus has been employed
as a model insect in vivo system to understand the cytogenetical
effects [17,24]. The diploid numbers of chromosome comple-
ments are 19 in males and 20 in females, which are large in size.
Furthermore, cells showing all the meiotic stages are available
in large numbers for cytological scrutiny. Hence, in the present
investigations, an attempt has been made to understand the
inﬂuence of hyperthermia on Ethyl methanesulfonate (EMS)
induced adaptive response in meiotic cells of the grasshopper
P. pictus.2. Materials and methods
2.1. Chemicals
The monofunctional alkylating agent Ethyl methanesulfonate
(EMS: CAS No. 62-50.0), an ethylating agent obtained from
Sigma Chemical Company, USA was used.
2.2. P. pictus
Male grasshoppers weighing 2.5–3 g were collected from the
environs of Mysore city and these were maintained in the
laboratory for 2–3 days until use.
2.3. Selection of chemical doses
In order to understand the adaptive response, the conditioning
and challenging doses of clastogen have to be selected. The
conditioning and challenging doses of EMS were established
in previous experiments with P. pictus [17,25]. The same doses
such as 0.03 M and 0.12 M EMS were used in the present study
as conditioning (L) and challenging (H) doses respectively.
2.4. Hyperthermia
Pilot toxicity studies were carried out to select the tempera-
tures (hyperthermia) and the time of exposure in the present
study. The grasshoppers were placed in the small cages and
hyperthermic exposure was carried out using BOD (biological
oxygen demand) incubator. Initial experiments were carried
out by subjecting grasshoppers to various temperatures rang-
ing from 38 C to 45 C with different times of exposure such
as 10, 15, 30 and 45 min. The higher temperatures of 40 C and
45 C with exposure time of 15 and 30 min were selected in the
present study. The effective hyperthermic temperatures were
chosen by understanding the mortality and frequency of
chromosomal anomalies produced.
2.5. Treatment schedules
EMS was dissolved in 0.4% NaCl solution. 50 lL of the ﬁxed
concentration of the chemical agent was injected into the
abdomen of the animal between 3rd and 4th segments. Each
time freshly prepared solution of agent was used.
(i) Control: The control group of grasshoppers received
50 lL of 0.4 % NaCl solution only.
(ii) Hyperthermia (HT): The grasshoppers were exposed to
40 and 45 C for 15 or 30 min respectively.
(iii) EMS treatment: In this treatment schedule, grasshop-
pers were treated with conditioning (L) or challenging
(H) doses of EMS.
(iv) Combined treatment of EMS: The previous studies
[17,25] have shown that the combined treatment of con-
ditioning and challenging doses of clastogen (EMS) with
2 h time lag (TL) between them offered appreciable pro-
tection in meiotic cells of P. pictus. Hence, in the present
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challenging dose of EMS (L-2 h-H) was employed to
understand the occurrence of adaptive response.
(v) Pre-treatments of hyperthermia: Grasshoppers were sub-
jected to hyperthermia 2 or 4 h prior to conditioning
dose of EMS and then they were challenged with same
clastogen after 2 h.
(1) [HT [40 C-15 min]-2 h-L-2 h-H].
(2) [HT [40 C-30 min]-2 h-L-2 h-H].
(3) [HT [45 C-15 min]-2 h-L-2 h-H].
(4) [HT [45 C-30 min]-2 h-L-2 h-H].
(5) [HT [40 C-15 min]-4 h-L-2 h-H].
(6) [HT [40 C-30 min]-4 h-L-2 h-H].
(7) [HT [45 C-15 min]-4 h-L-2 h-H].
(8) [HT [45 C-30 min]-4 h-L-2 h-H].(vi) Inter-treatments of hyperthermia: The grasshoppers were
subjected to hyperthermia in between the conditioning
and challenging treatment of EMS. Grasshoppers were
exposed to hyperthermia for one hour after conditioning
dose of EMS and one hour later they were challenged
with challenging dose of the same clastogen with 15 or
30 min time of hyperthermia.
(1) [L-1 h-HT [40 C-15 min]-1 h-H].
(2) [L-1 h-HT [40 C-30 min]-1 h-H].
(3) [L-1 h-HT [45 C-15 min]-1 h-H].
(4) [L-1 h-HT [45 C-30 min]-1 h-H].(vii) Post-treatments of hyperthermia: In this schedule
grasshoppers were exposed to hyperthermia, 2 or 4 h
after combined treatment (L-2 h-H) of EMS.(1) L-2 h-H-2 h-HT [40 C-15 min].
(2) L-2 h-H-2 h-HT [40 C-30 min].
(3) L-2 h-H-2 h-HT [45 C-15 min].
(4) L-2 h-H-2 h-HT [45 C-30 min].
(5) L-2 h-H-4 h-HT [40 C-15 min].
(6) L-2 h-H-4 h-HT [40 C-30 min].
(7) L-2 h-H-4 h-HT [45 C-15 min].
(8) L-2 h-H-4 h-HT [45 C-30 min].(viii) Cross adaptation: In this set of experimental schedule,
grasshoppers were exposed to hyperthermia ﬁrst and
then the same animals were challenged after 2 h with
challenging dose of EMS.(1) [HT [40 C-15 min]-2 h-H].
(2) [HT [40 C-30 min]-2 h-H].
(3) [HT [45 C-15 min]-2 h-H].
(4) [HT [45 C-30 min]-2 h-H].All the treated and control animals were maintained on
fresh Calotropis leaves in the respective cages. The grasshop-
pers were sacriﬁced at 12, 24, 36 or 48 h of recovery times. A
minimum of three experiments were carried out. A total of
12 animals were used for each treatment schedule.
2.6. Meiotic chromosome preparation
Chromosome preparations were made by following the proce-
dure of Riaz Mahmood and Vasudev [17]. In brief, Grasshop-
pers were sacriﬁced by decapitation. The testes were removedfrom the abdomen and ﬁxed in methanol/acetic acid
(3:1 v/v). Three changes of the ﬁxative for 15 min in each were
given to the material. Meanwhile, the testes were cleaned by
removing the fat and tracheae (respiratory organ of insect).
These testes were then kept in absolute methanol for 10 min.
They were then transferred and preserved in 70% ethyl alcohol
until further use. Each tubule of the testes was washed using
distilled water at the time of temporary chromosome prepara-
tion. They were then transferred to mordant, 4 % iron alum
(Ferric ammonium sulfate). After 20 min, these were stained
using Heidenhain’s hematoxylin stain for 30 min. The stained
tubules were washed using distilled water and 3–4 tubules were
placed on a clean, non-greasy, micro slide with few drops of
freshly prepared 45% acetic acid. Cover glass was placed after
5 min on the tubules and gently pressed using blotting paper.
The cover glass was sealed with wax.
2.7. Chromosome analysis
Coded slides from grasshoppers belonging to various treat-
ment regimen were screened to score the chromosomal anoma-
lies in the different stages of meiosis such as metaphase I,
anaphase I, metaphase II and anaphase II. The chromosomal
anomalies viz., stickiness, stickiness and clumping, fragments,
bridges, pseudobridges and laggards, were recorded. In each
grasshopper a minimum of 500 cells in each meiotic stage
and a total of 2000 cells were scored. Thus, a total of 24,000
meiotic cells in 12 grasshoppers were scored per each treatment
schedule.
2.8. Statistical analysis
The difference that exists among the mean differences in the
treatment groups was analyzed using the Duncan multiple
comparison post hoc test using the SPSS software (version
16.0). The Duncan post hoc test makes pairwise comparisons
using a stepwise order of comparisons among the treatment
groups.3. Results
The frequencies of different chromosomal anomalies such as
stickiness, stickiness and clumping, fragments, bridges, pseu-
dobridges and laggards that were observed after different
treatments are given in Table 1a. Stickiness and stickiness
and clumping were found to be prominent in EMS treatment
compared to that of controls and hyperthermia. Both condi-
tioning and challenging doses induced signiﬁcant anomalies
at different temperatures (40 C and 45 C) exposed to differ-
ent durations (15 and 30 min). Combined treatment with 2 h
TL between them resulted in 44–50% reduction of chromoso-
mal anomalies which is signiﬁcant compared to that of addi-
tive effect at 12, 24, 36 and 48 h recovery times (Table 1b).
Pre treatment of hyperthermia to EMS exposed cells
resulted in signiﬁcant reduction of the range of 59 to 67%
chromosomal anomalies compared to that of additive effects
(Table 2, p< 0.05). It is also evident when temperatures of
40 C and 45 C for 15 and 30 min with 2 h and 4 h time inter-
vals were used (Fig. 1). The frequencies of anomalies were
signiﬁcantly reduced when hyperthermia was given between
Table 1a Frequency (%) of individual chromosomal anomalies (mean ± SE) observed after hyperthermia (HT) or Ethyl methanesulfonate (EMS) treatment in meiotic cells of P. pictus
at 12 h recovery times (RTs).
Treatment
Groups
Metaphase I Anaphase I Metaphase II Anaphase II Total damage
St St & Cl Fr Br Lag Fr St St &Cl Fr PB Lag Fr
Control 1.35 ± 0.056 – – 0.05 ± 0.029 1.66 ± 0.034 – 3.58 ± 0.172 0.45 ± 0.055 – – – – 7.09 ± 0.249a
HT-40 C-
15 min
1.63 ± 0.059 – – 0.05 ± 0.039 1.59 ± 0.031 – 4.05 ± 0.174 0.57 ± 0.031 – – – – 7.89 ± 0.174a
HT-40 C-
30 min
1.60 ± 0.037 – – 0.10 ± 0.048 1.85 ± 0.070 – 3.58 ± 0.218 0.54 ± 0.056 – – – – 7.67 ± 0.270a
HT-45 C-
15 min
1.65 ± 0.022 – – 0.04 ± 0.021 2.15 ± 0.044 – 3.61 ± 0.086 0.53 ± 0.043 – – – – 7.98 ± 0.111a
HT-45 C-
30 min
1.45 ± 0.031 – – 0.03 ± 0.018 1.90 ± 0.038 – 4.07 ± 0.030 0.44 ± 0.020 – – – – 7.89 ± 0.066a
EMS-L 4.98 ± 0.117 1.21
± 0.036
1.59
± 0.041
1.29 ± 0.028 0.74 ± 0.104 – 18.60 ± 0.150 3.52 ± 0.069 2.84
± 0.090
2.28
± 0.047
0.40
± 0.037
– 37.45 ± 0.318b
EMS-H 8.10 ± 0.039 7.88
± 0.070
0.16
± 0.024
4.39 ± 0.055 1.48 ± 0.065 0.51
± 0.015
29.47 ± 0.143 28.94 ± 0.211 1.32
± 0.039
2.17
± 0.019
1.30
± 0.029
– 84.41 ± 1.271d
L-2 h-H 5.83 ± 0.113 5.83
± 0.145
0.95
± 0.088
1.13 ± 0.027 0.69 ± 0.032 – 28.42 ± 0.175 15.57 ± 0.115 0.43
± 0.061
1.10
± 0.086
1.08
± 0.032
0.02
± 0.012
67.54 ± 0.963c
Pooled data from three independent experiments; minimum of 500 cells in each meiotic stage per dose were scored; minimum of 4 grasshoppers per experiment were used.
Values with same superscripts are not signiﬁcant (p> 0.05); Values with different superscripts are signiﬁcantly different from one another (p< 0.05) according to Duncan Post hoc test.
St: stickiness; St&Cl: stickiness and clumping; Fr: fragments; Br: bridges; Lag: laggards; PB: pseudo bridges.
L: conditioning dose; H: challenging dose; HT: hyperthermic treatment.
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Table 1b Percentage of chromosomal anomalies (mean ± SE) observed after HT or EMS treatment in meiotic cells of P. pictus at
different RTs.
Treatment groups % Chromosomal anomalies at diﬀerent RT (in h)
12 24 36 48
Control 7.09 ± 0.249a 7.10 ± 0.125a 7.12 ± 0.071a 7.17 ± 0.096a
HT-40 C-15 min 7.89 ± 0.174a 7.66 ± 0.199a 7.55 ± 0.190a 7.52 ± 0.150a
HT-40 C-30 min 7.67 ± 0.270a 7.55 ± 0.097a 7.41 ± 0.166a 7.35 ± 0.167a
HT-45 C-15 min 7.98 ± 0.111a 7.81 ± 0.149a 7.75 ± 0.093a 7.67 ± 0.094a
HT-45 C-30 min 7.89 ± 0.066a 7.70 ± 0.056a 7.67 ± 0.212a 7.58 ± 0.088a
EMS-L 37.45 ± 0.318b 32.83 ± 0.306b 31.86 ± 0.252b 28.16 ± 0.208b
EMS-H 84.41 ± 1.271d 78.92 ± 0.264d 76.14 ± 0.334d 68.22 ± 0.497d
L-2 h-H 67.54 ± 0.963c 60.39 ± 0.207c 53.62 ± 0.432c 51.17 ± 0.463c
% Reduction 44.51 ± 1.001* 45.94 ± 0.352* 50.34 ± 0.441* 46.89 ± 0.544*
Note: Pooled data from three independent experiments; minimum of 500 cells in each meiotic stage per dose were scored; minimum of 4
grasshoppers per experiment were used. Values with same superscripts are not signiﬁcant (p> 0.05); values with different superscripts are
signiﬁcantly different from one another (p< 0.05) according to Duncan Post hoc test.
Individual chromosomal anomalies were scored as per Table 1a and pooled to make data concise, thus the percentage anomalies for different
recovery times are given in this table.
Calculation of percent reduction: (A) Additive effect: sum of chromosomal anomalies observed in both conditioning (L) and challenging (H) dose
(L + H); (B) combined Effect: chromosomal anomalies observed in combined treatment of conditioning and challenging doses with 2 h time lag
(L-2 h-H); percentage of reduction (C) was calculated by using formula: C= (B/A * 100)  100.
* Values are signiﬁcant compared to additive effect (p< 0.05).
Table 2 Percentage of chromosomal anomalies (mean ± SE) observed after pretreatment of HT to combine (conditioning and
challenging) doses of EMS treated meiotic cells of P. pictus at different RTs.
Treatment Groups % Chromosomal anomalies at diﬀerent RT (in h)
12 24 36 48
HT-40 C-15 min-2 h-L-2 h-H 47.49 ± 0.160f 45.42 ± 0.196f 39.35 ± 0.226f 38.32 ± 0.117f
HT-40 C-30 min-2 h-L-2 h-H 43.30 ± 0.084d 42.19 ± 0.098d 37.79 ± 0.124e 35.35 ± 0.156d
HT-45 C-15 min-2 h-L-2 h-H 46.33 ± 0.219ef 45.36 ± 0.157f 38.01 ± 0.141e 37.82 ± 0.175f
HT-45 C-30 min-2 h-L-2 h-H 43.02 ± 0.182d 42.14 ± 0.136d 37.00 ± 0.139e 35.13 ± 0.134d
HT-40 C-15 min-4 h-L-2 h-H 45.33 ± 0.118e 43.03 ± 0.203e 37.02 ± 0.124e 36.01 ± 0.101e
HT-40 C-30 min-4 h-L-2 h-H 42.83 ± 0.120d 42.01 ± 0.130d 36.13 ± 0.154d 35.03 ± 0.099d
HT-45 C-15 min-4 h-L-2 h-H 44.01 ± 0.164d 42.02 ± 0.186d 36.03 ± 0.087d 35.02 ± 0.094d
HT-45 C-30 min-4 h-L-2 h-H 41.05 ± 0.093c 40.04 ± 0.123c 34.68 ± 0.055c 34.00 ± 0.082c
Pooled data from three independent experiments; minimum of 500 cells in each meiotic stage per dose were scored; minimum of 4 grasshoppers
per experiment were used.
Values with same superscripts are not signiﬁcant (p> 0.05); values with different superscripts are signiﬁcantly different from one another
(p< 0.05) according to Duncan Post hoc test.
Individual chromosomal anomalies were scored as per Table 1a and pooled to make data concise, thus the percentage anomalies for different
recovery times are given in this table.
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ery times (p< 0.05; Table 3). The percentage reduction of
chromosomal anomalies is between 56 and 63%, which is sig-
niﬁcant (Fig. 2). There is a signiﬁcant decrease in anomalies in
post treatment of hyperthermia compared to combined treat-
ment of EMS (p< 0.05; Table 4). The percentage reduction
of chromosomal anomalies is between 47 and 55% (Fig. 3).
The treatment of hyperthermia prior to challenging dose (i.e.
hyperthermia + challenging dose) reduced chromosomal
anomalies signiﬁcantly compared to challenging dose at allrecovery times tested (Table 5; p< 0.05). The reduced yield
of chromosomal anomalies is around 32% at different temper-
atures and RTs (Fig. 4).
Although reductions of chromosomal anomalies were quite
different at different temperatures and time intervals, more
reductions of chromosomal anomalies were detected at 45 C
than at 40 C in all the pre, inter, post and cross adaptation treat-
ment schedule groups. This is also true for time intervals in that
2 h time interval noticed high anomaly frequency than at 4 h
time interval at all recovery times (Table 1a–5 and Figs. 1–4).
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HT [45°C-15minutes]-2h-L-2h-H HT [45°C-30minutes]-2h-L-2h-H
HT [40°C-15minutes]-4h-L-2h-H HT [40°C-30minutes]-4h-L-2h-H
HT [45°C-15minutes]-4h-L-2h-H HT [45°C-30 minutes]-4h-L-2h-H
Figure 1 Reduction (%) of chromosomal anomalies (mean ± SE) observed after pre treatment of hyperthermia (HT) compared to
additive effect of Ethyl methanesulfonate (EMS) at different RTs in P. pictus. Note: Additive effect: sum of chromosomal anomalies
observed in both conditioning and challenging doses (L + H); * values are signiﬁcant compared to additive effect (p< 0.05).
Table 3 Percentage of chromosomal anomalies (mean ± SE) observed after inter treatment of HT between conditioning and
challenging doses of EMS in meiotic cells of P. pictus at different RTs.
Treatment Groups % Chromosomal anomalies at diﬀerent RT (in h)
12 24 36 48
L-1 h-HT-40 C-15 min-1 h-H 48.04 ± 0.154e 46.04 ± 0.117f 44.78 ± 0.105f 42.22 ± 0.101d
L-1 h-HT-40 C-30 min-1 h-H 47.26 ± 0.068de 45.02 ± 0.083e 43.18 ± 0.082de 42.03 ± 0.097d
L-1 h-HT-45 C-15 min-1 h-H 46.12 ± 0.093cd 44.00 ± 0.052d 42.29 ± 0.075d 41.01 ± 0.112c
L-1 h-HT-45 C-30 min-1 h-H 45.29 ± 0.125c 43.00 ± 0.067c 41.02 ± 0.064c 40.57 ± 0.066c
Pooled data from three independent experiments; minimum of 500 cells in each meiotic stage per dose were scored; minimum of 4 grasshoppers
per experiment were used.
Values with same superscripts are not signiﬁcant (p> 0.05); values with different superscripts are signiﬁcantly different from one another
(p< 0.05) according to Duncan Post hoc test.
Individual chromosomal anomalies were scored as per Table 1a and pooled to make data concise, thus the percentage anomalies for different
recovery times are given in this table.
178 R. Venu et al.4. Discussion
4.1. Individual chromosome anomalies
Among different types of meiotic chromosomal anomalies
observed, the chromosome stickiness and stickiness and
clumping are the prominent ones with high frequencies
(Table 1a). In stickiness and clumping chromosome comple-
ment stuck together and formed irregular masses and in the
extreme clump the individuality of chromosome was lost.
Stickiness has been reported to be induced by a variety of
chemicals in grasshopper spermatocytes [26–28]. Variousbiochemical views on the stickiness and clumping have been
put forth by many workers. Stickiness results from the break-
down of chromosomal nucleic acid into the depolymerized and
ﬂuid state [29], the dissociation of nucleic acid into the nuclear
sap [30], high proteolytic activity [31] and excess of histone
might cross link DNA in the neighboring strands [32]. On
the basis of electron microscopic examination it was reported
that mammalian sticky chromosome and Allium cepa root
tip induced by chemicals possess ﬁne ﬁbrous connections
between chromosomes and supposed that these are chromatid
ﬁbers [27]. From this, it can be concluded that chromosome
stickiness is a chromatid type of aberration.
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Figure 2 Reduction (%) of chromosomal anomalies (mean ± SE) observed after inter treatment of HT compared to additive effect of
EMS at different RTs in P. pictus. Note: Additive effect: sum of chromosomal anomalies observed in both conditioning and challenging
doses (L + H); * values are signiﬁcant compared to additive effect (p< 0.05).
Table 4 Percentage of chromosomal anomalies (mean ± SE) observed after post treatment of HT to combined (conditioning and
challenging) EMS dosed in meiotic cells of P. pictus at different RTs.
Treatment Groups % Chromosomal anomalies at diﬀerent RT (in h)
12 24 36 48
L-2 h-H-2 h-HT-40 C-15 min 60.52 ± 0.052f 59.16 ± 0.085i 52.13 ± 0.094h 50.57 ± 0.112gh
L-2 h-H-2 h-HT-40 C-30 min 59.22 ± 0.044de 58.31 ± 0.075h 51.46 ± 0.052gh 49.54 ± 0.184ef
L-2 h-H-2 h-HT-45 C-15 min 59.49 ± 0.051ef 58.95 ± 0.050i 52.26 ± 0.958h 50.11 ± 0.076fg
L-2 h-H-2 h-HT-45 C-30 min 58.04 ± 0.076d 57.30 ± 0.028g 50.70 ± 0.133fg 48.52 ± 0.295d
L-2 h-H-4 h-HT-40 C-15 min 59.03 ± 0.028de 56.29 ± 0.067f 50.11 ± 0.088ef 49.33 ± 0.060e
L-2 h-H-4 h-HT-40 C-30 min 58.50 ± 0.042de 55.50 ± 0.058e 49.51 ± 0.078de 47.95 ± 0.068d
L-2 h-H-4 h-HT-45 C-15 min 57.94 ± 0.031d 54.42 ± 0.053d 49.06 ± 0.065d 48.07 ± 0.226d
L-2 h-H-4 h-HT-45 C-30 min 56.09 ± 0.057c 53.25 ± 0.041c 48.06 ± 0.058c 46.46 ± 0.053c
Pooled data from three independent experiments; minimum of 500 cells in each meiotic stage per dose were scored; minimum of 4 grasshoppers
per experiment were used.
Values with same superscripts are not signiﬁcant (p> 0.05); values with different superscripts are signiﬁcantly different from one another
(p < 0.05) according to Duncan Post hoc test.
Individual chromosomal anomalies were scored as per Table 1a and pooled to make data concise, thus the percentage anomalies for different
recovery times are given in this table.
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The decrease in chromosomal anomalies after combined
treatments in comparison with challenge or additive doses
must be due to the induction of protective function (adaptive
response), by low dose of EMS in meiotic cells of P. pictus
(Table 1b). Similar results have been recorded in the induction
of adaptive response in V. faba, P. pictus and humanlymphocytes by alkylating agents [17,19,33–35]. The results
of the present investigations, together with previous investiga-
tions indicate that the factors involved in the adaptive response
may be very complex in eukaryotic systems. Most of the stud-
ies revealed in plants and human lymphocytes in vitro that clas-
togenic adaptation depends on unimpaired protein synthesis
[37] and on metabolic state of the cells. These ﬁndings indicate
the presence of inducible protective functions (possible repair
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Figure 3 Reduction (%) of chromosomal anomalies (mean ± SE) observed after post treatment of HT compared to additive effect of
EMS at different RTs in P. pictus. Note: Additive effect: sum of chromosomal anomalies observed in both conditioning and challenging
doses (L + H); * values are signiﬁcant compared to additive effect (p< 0.05 level).
Table 5 Percentage of chromosomal anomalies (mean ± SE) observed in meiotic cells of P. pictus treated with HT and challenging
with high dose of EMS at different RTs.
Treatment Groups % Chromosomal anomalies at diﬀerent RT (in h)
12 24 36 48
HT-40 C-15 min-2 h-H 58.14 ± 0.117e 56.20 ± 0.069e 52.56 ± 0.086f 49.06 ± 0.533ef
HT-40 C-30 min-2 h-H 57.26 ± 0.024de 55.39 ± 0.067d 51.29 ± 0.033e 48.13 ± 0.073de
HT-45 C-15 min-2 h-H 56.05 ± 0.075cd 54.74 ± 0.103c 49.74 ± 0.043d 47.06 ± 0.039cd
HT-45 C-30 min-2 h-H 55.05 ± 0.090c 54.26 ± 0.300c 48.49 ± 0.079c 46.17 ± 0.050c
Pooled data from three independent experiments; minimum of 500 cells in each meiotic stage per dose were scored; minimum of 4 grasshoppers
per experiment were used.
Values with same superscripts are not signiﬁcant (p> 0.05); values with different superscripts are signiﬁcantly different from one another
(p< 0.05) according to Duncan Post hoc test.
Individual chromosomal anomalies were scored as per Table 1a and pooled to make data concise, thus the percentage anomalies for different
recovery times are given in this table.
180 R. Venu et al.activities). Even though the adaptive repair system in bacteria
is well demonstrated [36], the situation as to the existence of
such a mechanism in mammalian cells is not yet clear.
Furthermore underlying mechanisms of clastogenic adaptation
in mammalian in vivo systems are presently unknown that too
in meiotic cells.
In all the treatments, different recovery times (ﬁxed times)
have been employed after the challenge treatment. If one
recovery time was selected, then one would have argued that
the reduced anomalies’ yields observed after differenttreatments are due to the effects of pre treatment in the cell
cycle. To exclude this argument in the present investigations,
different recovery times were selected to study the induction
of protection in different cell population in P. pictus. It was
suggested that the response ceases after the third mitosis of
adapted cells, due to a dilution of the repair system as the cells
divide over subsequent cell cycles [37]. This agrees with earlier
reports where it has been fully proved that the decrease in
anomaly frequency with increasing culture time reﬂects a
mechanism of mitotic selection of anomalies bearing cells.
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(L + H); * values are signiﬁcant compared to additive effect (p< 0.05).
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cytogenetic adaptive response
Hyperthermia of 40 C or 45 C could not induce signiﬁcant
anomalies in meiotic cells of P. pictus at different time intervals
at all recovery times analyzed compared to that of controls and
thus it can be said that hyperthermia could not induce any
lesions (p> 0.05; Table 1b). On par with this, similar observa-
tions were made by earlier workers [38,39]. Contrary to these,
it has been demonstrated that hyperthermia could induce chro-
mosomal aberrations in in vitro Chinese hamster ovary (CHO)
cells [40] in He La cells [41] and human A549 cells [42]. Review
of literature thus, reveals that there are conﬂicting reports on
the effects of hyperthermia on chromosome on one hand and
on the other there are no sufﬁcient reports on the effects of
hyperthermia using in vivo systems.
The signiﬁcant decrease of chromosomal anomalies in
meiotic cells of P. pictus (p< 0.05; Table 2), after pretreat-
ment of hyperthermia demonstrates the enhancement of adap-
tive response by hyperthermia in in vivo system. Cai and Jiang
[13] working with human lymphocytes have demonstrated
that, hyperthermia and adaptive dose + challenging dose with
an interval of 6 h reduced the number of chromatid and
isochromatid breaks to 30 to 70%. The absence of additive
effect after second adaptive dose was hypothesized to be due
to the saturation effect of a single adaptive dose [13]. Interest-
ingly, the present results demonstrated that, hyperthermia as
the ﬁrst adaptive dose and EMS as the second adaptive dose
induced highly signiﬁcant adaptation to subsequent challengedose of the said agent in P. pictus. For example combined
doses of EMS (L + H) resulted in 60.39% reduction on one
hand and 66.33% in combined treatments of hyperthermia
+ adaptive dose of EMS + high dose of EMS in meiotic cells
of P. pictus at 24 h recovery time (Fig. 1). These results suggest
that, there is more additive or nearly synergistic effects proving
that the adaptation induced by hyperthermia involves the
different mechanisms compared to chemical adaptation.
The primary heat treatment and heating time for the degree
and kinetics of thermotolerance in the treatment of carcinoma
is very important. Preheating of the tumors at 43.5 C for 3.5,
7.5, 15, 30, or 45 min, showed that, both the thermotolerance
ratio and the time interval which are necessary to develop ther-
motolerance ratio increased, both being linear functions of the
duration of the preheating time. Maximal thermotolerance was
obtained at intervals of 2, 4, 8, 16 and 28 h with thermotoler-
ance ratio of 1.6, 2.2, 3.7, 5.2 and 7.7 respectively [43]. Rieger
and Michaelis [44] have shown reduction in maleic hydrazide
or triethylenemelamine induced chromatid aberrations in the
cells which are pre exposed to heat shock (10 min; 40 C). They
also demonstrated that the protective function of heat shock is
a quick response which lasts up to 240 min and suggests that
heat shock before clastogen treatment triggers clastogen-
speciﬁc, protective functions which eventually result in
protection against clastogens. Similarly, there was reduction
in the chromatid aberrations in V. faba seedlings which are
pre treated with sub-lethal heat shock (10 min, 40 C) and then
challenged with N-Methyl-N-Nitrosourea (MNU) when
compared to challenging treatment of MNU alone [45]. These
182 R. Venu et al.evidences indicate the beneﬁcial role of conditioning treatment
of heat shock in reducing DNA damages.
4.4. Influence of hyperthermia inter-treatment on EMS induced
cytogenetic adaptive response
The inter treatment of hyperthermia (L-1 h-HT-1 h-H) with
EMS yielded signiﬁcantly less frequency of chromosomal
anomalies compared to combined treatment (L-2 h-H)
indicating the enhancement of adaptive response in P. pictus
(p< 0.05; Table 3). On par with these results, Cai and Jiang
[13] working with human lymphocytes in the combination of
hyperthermia inter treatment such as (i) adaptive dose
(50 mGy X rays) and hyperthermia (0 h, 41 C for 1 h) +
challenging dose (1.5 Gy X rays) (ii) adaptive dose (50 mGy
X rays) and hyperthermia (14 h, 41 C for 1 h) + challenging
dose (1.5 Gy X rays) (iii) adaptive dose (50 mGy X rays) and
hyperthermia (38 h, 41 C for 1 h) + challenging dose (1.5 Gy
X rays) (iv) adaptive dose (50 mGy X rays) + hyperthermia
(42 h, 41 C for 1 h) + challenging dose (1.5 Gy X rays)
together reduced the chromatid and isochromatid breaks of
the effects induced by challenge dose alone. Bleomycin
(10 mg/kg) given intra peritoneal before heat and then
radiation was administered as 5 fractions of 3 Gy resulting
in increased growth delay up to 14.5 days in FSaIIC ﬁbrosar-
coma tumor cells [46]. As has been discussed in the pre
treatments even inter treatment of hyperthermia showed
clasto-resistance irrespective of time and temperature (Fig. 2).
4.5. Influence of hyperthermia post treatment on EMS induced
cytogenetic adaptive response
In the post treatments of hyperthermia after 2 h or 4 h time
interval in P. pictus yielded signiﬁcantly lower frequencies of
chromosomal anomalies compared to combined treatments
at all recovery times (p< 0.05; Table 4). Administering the
Bleomycin followed by radiation then hyperthermia as a post
treatment, produced 1.5 to 2.5-fold greater tumor cell killing
than did radiation-Bleomycin-hyperthermia in FSaIIC
ﬁbrosarcoma tumor cell line [46]. Contrary to the present ﬁnd-
ing post treatments of heat treated cells with Trenimone (tri-
functional alkylating agent) have synergetic effects on the
frequency of chromatid intra and inter changes and this effect
can be seen when the cells are recovered after 16, 18 or 22 h in
the presence of BrdU [47]. The present results show that adap-
tive dose + challenge along with hyperthermia of different
temperature and time intervals can induce the adaptation to
cytogenetic damage in P. pictus. Unlike pre and inter treat-
ments, in these schedules 45 C induced more or less same
adaptation at 40 C in P. pictus at all recovery times (Fig. 3).
4.6. Influence of hyperthermia on EMS induced cytogenetic
cross adaptive response
It is well established that chemotherapy in most cases has the
greatest effect when administered during the heating interval
[48]. When heat is given prior to the administration of the
drugs/radiation, it can actually increase the resistance/adapta-
tion of the cell/tissue/organisms to that particular therapeutic
agent. Thus, in the present study, when P. pictus was exposed
to hyperthermia ﬁrst and then the same animals werechallenged with high dose of EMS it yielded signiﬁcantly
reduced chromosomal anomalies compared to that of com-
bined treatment (p< 0.05; Table 5). This suggests that there
is cross adaptation in meiotic cells. Similarly, an adaptive
response to mild hyperthermia was ﬁrst observed in Escheri-
chia coli by Cairns and his collaborators [49] and then human
lymphocytes [50]. A mild heat shock induced a cross-
protection against lethal salt stress in bacteria Bacillus subtilis
[51]. When CHO cells preheated for varying times at 43 C,
cells became progressively more resistant to subsequent Adra-
mycine treatment [52]. Exposure to 43 C with actinomycin D
for more than 30 min or preheating at 43 C before drug expo-
sure, both reduced the cytotoxicity of actinomycin D [53]. The
EMT6 mouse tumor cells were preheated for 3 h at 40 C along
with cytotoxic agents that produced measurable protection
(thermal tolerance) to subsequent treatment for 1 h at 43 C.
This preheat treatment was further found to reduce cell killing
by bleomycin (BLM) and 1,3-bis(2-chlorethyl)nitrosourea
(BCNU) (drug tolerance) present during 1 h at 43 C [54]. Heat
prior to the administration of the drugs such as adriamycin or
actinomycin D can actually increase the resistance of the cell to
the chemotherapeutic agents [48]. Vasudev and Obe [47] have
demonstrated the pretreatment of CHO cells with heat
(46 C for 6 min) led to a reduction of Alu-I restriction
endonuclease induced chromosome aberrations.
The results at the end of each exposure period also showed
that there is a signiﬁcant more production of anomalies at
40 C compared to 45 C in P. pictus at all recovery times
(Figs. 1–4) tested. When hyperthermia was pre treated with
challenge dose of radiation (X-rays) it resulted in signiﬁcantly
reduced number of chromatid and isochromatid breaks com-
pared to challenge dose at different time intervals of 0, 14,
38 and 42 h [13]. Heat shock treatment for 10 or 30 min 1 or
2 h prior to maleic hydrazide (MH) [55] or MNU [45] resulted
in a signiﬁcant decrease in the percentage of metaphases with
chromatid aberrations at different recovery times tested. Even
though similar results were obtained when triethylene mela-
mine (TEM) instead of MH was used; prolongation of time
interval i.e. 2 h instead of 1 h between heat shock and TEM
resulted in aberrations yield approaching the control value.
A shorter heat shock (10 min) proved to be insufﬁcient to
lower the TEM effects over the different recovery times tested.
In the present investigations, heat treatments for 15 to 30 min
applied 2 h prior to EMS in P. pictus; resulted in a signiﬁcant
decrease in chromosomal anomalies in P. pictus for the whole
range of recovery times tested (Tables 2–5). Thus, heat
treatment prior to EMS applications reduced the clastogenic
activity of both the agents efﬁciently with same time span.
Early experiments with human lymphocytes revealed that
full adaptation to ionizing radiation did not occur until 4 to
6 h after the adapting dose [56]. This observation is generally
explained by the necessity of protein synthesis for the adapta-
tion to occur. Recent observations further support this,
although the time necessary for adaptation appears to be vari-
able [21]. Thus, an adapting dose was only capable of reducing
the frequency of neoplastic transformation when the cells were
left in contact inhibition for 24 h before plating [57,58].
Moreover, in mammalian cell culture systems, a low dose of
0.02 Gy delivered 5 h before a challenged dose signiﬁcantly
enhanced the survival rate and resulted in a reduction of
induced chromosomal aberrations [59].
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Hyperthermic treatment could not induce signiﬁcant chromoso-
mal anomalies compared to that of control at different recovery
times in P. pictus. The pre, inter and post treatments of hyper-
thermia to combined treatments have signiﬁcantly reduced the
yield of chromosomal anomalies compared to challenge dose
of EMS in in vivo test system analyzed. When P. pictus was
exposed to hyperthermia ﬁrst and then the same animals were
challenged with high dose of EMS, the results have revealed that
there are signiﬁcantly reduced chromosomal anomalies com-
pared to combined treatment at different recovery times. Thus,
the overall data of the present study demonstrate that there is
enhanced inﬂuence of hyperthermia on EMS induced adaptive
response in in vivo system of P. pictus and strengthened that
there is high activity of repair mechanisms.Declaration of interest
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